TMS Co., Ltd. (TYO:4891)
Japan · Delayed Price · Currency is JPY 139.00
+7.00 (5.30%)
Oct 26, 2026, 3:30 PM JST
TMS Co., Ltd. Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
6.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Feb 28, 2025 | - | - | - |
| Feb 29, 2024 | - | - | - |
| Feb 28, 2023 | - | - | - |
| Feb 28, 2022 | 1.95B | - | - |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Soiken Holdings | 3.87B |
| CellSource | 3.67B |
| StemCell Institute | 2.81B |
| MEDINET | 998.00M |
| Chiome Bioscience | 615.15M |
| SUSMED,Inc. | 497.00M |
| Kringle Pharma | 342.21M |
| Cyfuse Biomedical K.K. | 305.00M |